Finance

Lists
TMAN:BKK
T Man Pharmaceutical PCL
THB 10.30
-0.96%
(-0.100) 1D
Oct 15, 4:40:00 PM GMT+7  ·   THB
All symbols
SymbolPriceChange% Change
Generating top insights for TMAN...
Open
THB 10.40
High
THB 10.50
Low
THB 10.30
Mkt. cap
4.12B
Avg. vol.
332.63K
Volume
221.82K
Dividend
5.44%
Quarterly dividend
THB 0.14
Ex-dividend date
Aug 26, 2026
P/E ratio
8.16
52-wk high
THB 13.60
52-wk low
THB 9.95
EPS
THB 1.26
Shares outstanding
400.00M
No. of employees
1K
Open
THB 10.40
High
THB 10.50
Low
THB 10.30
Mkt. cap
4.12B
Avg. vol.
332.63K
Volume
221.82K
Dividend
5.44%
Quarterly dividend
THB 0.14
Ex-dividend date
Aug 26, 2026
P/E ratio
8.16
52-wk high
THB 13.60
52-wk low
THB 9.95
EPS
THB 1.26
Shares outstanding
400.00M
No. of employees
1K
News stories
From web sources and news partners
About T Man Pharmaceutical PCL
CEO-
Employees1.05K
Founded1972
Headquarters-
SectorPharmaceutical industry
Websitetmanpharmaceutical.com
Previous reportsAll values in THB
Loading Previous Earnings...
Revenue
Net income
All values in THB
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
661.41M
730.15M
633.71M
594.36M
Cost of goods sold
377.69M
392.07M
338.37M
321.04M
Cost of revenue
377.69M
392.07M
338.37M
321.04M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
143.41M
175.59M
151.39M
155.05M
Operating expense
145.32M
177.27M
150.88M
151.66M
Total operating expenses
523.02M
569.34M
489.25M
472.70M
Operating income
138.40M
160.81M
144.46M
121.66M
Other non operating income
-
-
-
-
EBT including unusual items
131.64M
212.45M
139.82M
118.02M
EBT excluding unusual items
131.64M
155.00M
139.82M
118.02M
Income tax expense
19.04M
30.67M
25.18M
20.44M
Effective tax rate
14.47%
14.44%
18.01%
17.32%
Other operating expenses
-
-
-
-
Net income
112.60M
181.79M
114.63M
97.58M
Net profit margin
17.02%
24.90%
18.09%
16.42%
Earnings per share
-
0.46
0.29
-
Interest and investment income
-
-
-
-
Interest expense
-6.76M
-5.81M
-4.64M
-3.64M
Net interest expenses
-6.76M
-5.81M
-4.64M
-3.64M
Depreciation and amortization charges
-
-
-
-
EBITDA
168.50M
185.85M
182.21M
158.76M
Gain or loss from assets sale
-
-195.74K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps